supply of coronary drug eluting stentscoronary drug eluting stents,srph153052-coronary drug eluting stents (1) single wire technology on cobalt based alloy platform (2) stent with coating of biolinx polymer carrier for active drug zot arolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter sho uld be from 2.25 mm to 4 mm and length of the stent from 12mm to 38 mm. (4) the strut thick ness should be 81 micron or less. (5) stent delivery system should be monorail (single oper ator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years long term efficacy and sa fety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (i st) should be documented / published in peer reviewed scientific journals.(10) the document s pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply o f the stent to a major government institute.unit:no [ warranty period: 30 months after the date of delivery ] ]